##analysisDate=2018-07-31-22-23-45000
##analyzedBy=User1
##exportDate=2018-08-21-15-00-11000
##analysisName=Seraseq-DNA_RNA-07252018_v1_79026a9c-e0ff-4a32-9686-ead82c35f793
##workflowName=copy of Oncomine Focus w2.1 - DNA and Fusions - Single Sample_8a773813-7561-4f07-8516-660bc895e42e
##sampleNames=Seraseq-DNA_RNA-07252018_v1:Seraseq-DNA_RNA-07252018_RNA_v1
##reference=hg19
##variantGroup=DEFAULT
##filterChain=Oncomine Variants, 5% CI CNV ploidy >= gain of 2 over normal
##searchText=
##chromosome=All
##totalVariantCount=829
##filterInCount=35
##filteredOutCount=794
##hiddenVariantCount=0
Locus	Genotype	Ref	Type	No Call Reason	Genes	Location	Length	Oncomine Variant Class	Oncomine Gene Class	Copy Number	CytoBand	Info	Variant ID	Variant Name	% Frequency	Amino Acid Change	Read Counts	Coverage	Allele Ratio	CNV Confidence	Detection	3'/5' Imbalance	COSMIC/NCBI	Read Counts Per Million	Strand	Exon	Transcript	Coding	Variant Effect	PhyloP	SIFT	Grantham	PolyPhen	PFAM	dbSNP	DGV	MAF	EMAF	AMAF	GMAF	UCSC Common SNPs	Gene Ontology	DrugBank	ClinVar	p-value	Phred QUAL Score	Allele Coverage	CNV Precision	Ref+/Ref-/Var+/Var-	Homopolymer Length	Tiles
chr1:115256529	TG/CG	TG	SNV		NRAS	exonic	1	Hotspot	Gain-of-function			HS	COSM583;COSM584;COSM582;COSM12725;COSM579		AA=0.00, AG=0.00, CG=11.27, CT=0.00, GG=0.00	p.Gln61Arg		1996	TG=0.8873, AA=0.0, AG=0.0, CG=0.1127, CT=0.0, GG=0.0		Present				-	3	NM_002524.4	c.182A>G	missense	2.12,2.62	0.0	43.0	0.214	Miro-like protein,Ras family	rs11554290,rs121913254							GTP binding,GTPase activity,Golgi apparatus,Golgi membrane,MAPKKK cascade,Ral guanyl-nucleotide exchange factor activity,Ras protein signal transduction,actin cytoskeleton organization,activation of MAPKK activity,axon guidance,blood coagulation,epidermal growth factor receptor signaling pathway,insulin receptor signaling pathway,leukocyte migration,membrane fraction,nerve growth factor receptor signaling pathway,nucleotide binding,plasma membrane,positive regulation of Rac protein signal transduction,positive regulation of cell proliferation,regulation of long-term neuronal synaptic plasticity,regulation of synaptic transmission, GABAergic,signal transduction,small GTPase mediated signal transduction,striated muscle cell differentiation,visual learning		other,pathogenic	0.00001	519.669	TG=1771, AA=0, AG=0, CG=225, CT=0, GG=0		TG=1000/771, AA=0/0, AG=0/0, CG=137/88, CT=0/0, GG=0/0	2,2,2,2,2	
chr1:154142875 - chr1:156844362			FUSION		TPM3(7) - NTRK1(10)			Fusion	Gain-of-function				TPM3-NTRK1.T7N10.COSF1318				26393				Present		COSF1318	7.6588e-08		7																				0.0					
chr1:156100564 - chr1:156844697			FUSION		LMNA(2) - NTRK1(11)			Fusion	Gain-of-function				LMNA-NTRK1.L2N11				6103				Present			1.7710e-08		2																				0.0					
chr1:205649521 - chr7:140494267			FUSION		SLC45A3(1) - BRAF(8)			Fusion	Gain-of-function				SLC45A3-BRAF.S1B8.COSF871				14817				Present		COSF871	4.2996e-08		1																				0.0					
chr2:42522656 - chr2:29446394			FUSION		EML4(13) - ALK(20)			Fusion	Gain-of-function				EML4-ALK.E13A20.AB462411				18147				Present		AB462411	5.2660e-08		13																				0.0					
chr2:113992970 - chr3:12421202			FUSION		PAX8(9) - PPARG(2)			Fusion	Gain-of-function				PAX8-PPARG.P9P2.COSF1217				19340				Present		COSF1217	5.6121e-08		9																				0.0					
chr2:209113113	G/A	G	SNV		IDH1	exonic	1	Hotspot	Gain-of-function			HS	COSM28747;COSM28749;COSM28748		A=11.15, C=0.00, T=0.00	p.Arg132Cys		2000	G=0.8885, A=0.1115, C=0.0, T=0.0		Present				-	4	NM_005896.3	c.394C>T	missense	2.62	0.0	180.0	0.259	Isocitrate/isopropylmalate dehydrogenase	rs121913499							2-oxoglutarate metabolic process,NAD binding,NADPH regeneration,carbohydrate metabolic process,cellular lipid metabolic process,cytoplasm,cytosol,glutathione metabolic process,glyoxylate cycle,isocitrate dehydrogenase (NADP+) activity,isocitrate metabolic process,magnesium ion binding,mitochondrion,oxidoreductase activity,oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,peroxisomal matrix,peroxisome,protein homodimerization activity,response to oxidative stress,tricarboxylic acid cycle	2'-Monophosphoadenosine 5'-Diphosphoribose,Isocitric Acid	untested	0.00001	510.016	G=1777, A=223, C=0, T=0		G=1017/760, A=128/95, C=0/0, T=0/0	1,1,1	
chr3:41266124	A/G	A	SNV		CTNNB1	exonic	1	Hotspot	Gain-of-function			HS	COSM5688;COSM5664;COSM5716		C=0.00, G=10.61, T=0.00	p.Thr41Ala		1999	A=0.8939, C=0.0, G=0.1061, T=0.0		Present				+	3	NM_001904.3	c.121A>G	missense	2.26	0.0	58.0	0.94	Armadillo/beta-catenin-like repeat	rs121913412							APC-Axin-1-beta-catenin complex,Axin-APC-beta-catenin-GSK3B complex,DNA binding,I-SMAD binding,R-SMAD binding,RPTP-like protein binding,SMAD binding,Schwann cell proliferation,Scrib-APC-beta-catenin complex,T cell differentiation in thymus,Wnt receptor signaling pathway,Z disc,adherens junction,adherens junction assembly,alpha-catenin binding,androgen receptor binding,androgen receptor signaling pathway,anterior/posterior axis specification,apical part of cell,apoptotic process,basolateral plasma membrane,beta-catenin-TCF7L2 complex,bone resorption,branching involved in ureteric bud morphogenesis,cadherin binding,canonical Wnt receptor signaling pathway,canonical Wnt receptor signaling pathway involved in negative regulation of apoptosis,canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation,canonical Wnt receptor signaling pathway involved in positive regulation of epithelial to mesenchymal transition,catenin complex,cell adhesion,cell cortex,cell fate specification,cell junction,cell maturation,cell periphery,cell-cell adherens junction,cell-cell adhesion,cell-cell junction,cell-matrix adhesion,cell-substrate adherens junction,cellular component disassembly involved in apoptosis,cellular response to growth factor stimulus,cellular response to indole-3-methanol,cellular response to organic cyclic compound,central nervous system vasculogenesis,centrosome,chromatin binding,cytoplasm,cytoskeletal anchoring at plasma membrane,cytoskeleton,cytosol,dendritic shaft,desmosome,determination of dorsal/ventral asymmetry,dorsal/ventral axis specification,double-stranded DNA binding,ectoderm development,embryonic arm morphogenesis,embryonic axis specification,embryonic digit morphogenesis,embryonic foregut morphogenesis,embryonic heart tube development,embryonic hindlimb morphogenesis,embryonic limb morphogenesis,embryonic skeletal limb joint morphogenesis,endoderm formation,endodermal cell fate commitment,endothelial tube morphogenesis,enzyme binding,epithelial cell differentiation involved in prostate gland development,epithelial to mesenchymal transition,estrogen receptor binding,fascia adherens,forebrain development,fungiform papilla formation,gastrulation with mouth forming second,genitalia morphogenesis,glial cell fate determination,hair cell differentiation,hair follicle morphogenesis,hair follicle placode formation,hemopoiesis,hindbrain development,in utero embryonic development,internal side of plasma membrane,ion channel binding,ionotropic glutamate receptor binding,kinase binding,lamellipodium,lateral plasma membrane,lens morphogenesis in camera-type eye,limb development,liver development,lung cell differentiation,lung induction,lung-associated mesenchyme development,male genitalia development,membrane,membrane fraction,mesenchymal cell proliferation involved in lung development,mesenchymal to epithelial transition involved in metanephros morphogenesis,metanephros morphogenesis,microvillus membrane,midgut development,morphogenesis of embryonic epithelium,muscle cell differentiation,myoblast differentiation,negative regulation of cell proliferation,negative regulation of chondrocyte differentiation,negative regulation of heart induction by canonical Wnt receptor signaling pathway,negative regulation of oligodendrocyte differentiation,negative regulation of osteoclast differentiation,negative regulation of transcription from RNA polymerase II promoter,negative regulation of transcription, DNA-dependent,nephron tubule formation,neuron projection,nuclear hormone receptor binding,nucleus,odontogenesis of dentin-containing tooth,oocyte development,oviduct development,pancreas development,patterning of blood vessels,perinuclear region of cytoplasm,plasma membrane,positive regulation of I-kappaB kinase/NF-kappaB cascade,positive regulation of MAPKKK cascade,positive regulation of anti-apoptosis,positive regulation of apoptotic process,positive regulation of branching involved in lung morphogenesis,positive regulation of determination of dorsal identity,positive regulation of endothelial cell differentiation,positive regulation of epithelial cell proliferation involved in prostate gland development,positive regulation of fibroblast growth factor receptor signaling pathway,positive regulation of heparan sulfate proteoglycan biosynthetic process,positive regulation of mesenchymal cell proliferation,positive regulation of muscle cell differentiation,positive regulation of osteoblast differentiation,positive regulation of transcription from RNA polymerase II promoter,positive regulation of transcription, DNA-dependent,protein C-terminus binding,protein binding,protein kinase binding,protein localization at cell surface,protein phosphatase binding,protein-DNA complex,proximal/distal pattern formation,regulation of T cell proliferation,regulation of angiogenesis,regulation of calcium ion import,regulation of centriole-centriole cohesion,regulation of centromeric sister chromatid cohesion,regulation of fibroblast proliferation,regulation of myelination,regulation of nephron tubule epithelial cell differentiation,regulation of protein localization at cell surface,regulation of smooth muscle cell proliferation,renal inner medulla development,renal outer medulla development,renal vesicle formation,repressing transcription factor binding,response to cadmium ion,response to cytokine stimulus,response to drug,response to estradiol stimulus,response to hormone stimulus,sequence-specific DNA binding transcription factor activity,signal transducer activity,skeletal system development,skin development,smooth muscle cell differentiation,spindle pole,structural molecule activity,synapse,synapse organization,synaptic vesicle transport,thymus development,tongue morphogenesis,trachea formation,transcription coactivator activity,transcription factor binding,transcription factor complex,transcription regulatory region DNA binding,zonula adherens	Urea	other	0.00001	449.995	A=1787, C=0, G=212, T=0		A=760/1027, C=0/0, G=92/120, T=0/0	1,1,1	
chr3:178936091	G/A	G	SNV		PIK3CA	exonic	1	Hotspot	Gain-of-function			HS	COSM763;COSM27133		A=9.30, C=0.00	p.Glu545Lys		2000	G=0.907, A=0.093, C=0.0		Present				+	10	NM_006218.2	c.1633G>A	missense	2.72	0.0	56.0	0.991	PI3-kinase family,Phosphatidylinositol 3- and 4-kinase,Phosphoinositide 3-kinase C2,Phosphoinositide 3-kinase family	rs104886003							1-phosphatidylinositol-3-kinase activity,ATP binding,T cell costimulation,T cell receptor signaling pathway,angiogenesis,anti-apoptosis,blood coagulation,cytosol,epidermal growth factor receptor signaling pathway,fibroblast growth factor receptor signaling pathway,glucose metabolic process,hypomethylation of CpG island,insulin receptor signaling pathway,insulin receptor substrate binding,kinase activity,lamellipodium,leukocyte migration,nerve growth factor receptor signaling pathway,nucleotide binding,phosphatidylinositol 3-kinase complex,phosphatidylinositol phosphorylation,phosphatidylinositol-4,5-bisphosphate 3-kinase activity,phosphatidylinositol-mediated signaling,phosphotransferase activity, alcohol group as acceptor,platelet activation,positive regulation of peptidyl-serine phosphorylation,protein binding,protein kinase B signaling cascade,protein kinase activator activity,protein phosphorylation,protein serine/threonine kinase activity,regulation of multicellular organism growth,signal transduction	(1S,6BR,9AS,11R,11BR)-9A,11B-DIMETHYL-1-(METHYLOXY)METHYL-3,6,9-TRIOXO-1,6,6B,7,8,9,9A,10,11,11B-DECAHYDRO-3H-FURO4,3,2-DEINDENO4,5-H2BENZOPYRAN-11-YL ACETATE	other,pathogenic	0.00001	322.917	G=1814, A=186, C=0		G=886/928, A=99/87, C=0/0	1,1	
chr3:178952085	A/G	A	SNV		PIK3CA	exonic	1	Hotspot	Gain-of-function			HS	COSM249874;COSM775;COSM776		C=0.00, G=10.90, T=0.00	p.His1047Arg		2000	A=0.891, C=0.0, G=0.109, T=0.0		Present				+	21	NM_006218.2	c.3140A>G	missense	2.33	0.01	29.0	0.639	PI3-kinase family,Phosphatidylinositol 3- and 4-kinase,Phosphoinositide 3-kinase C2,Phosphoinositide 3-kinase family	rs121913279							1-phosphatidylinositol-3-kinase activity,ATP binding,T cell costimulation,T cell receptor signaling pathway,angiogenesis,anti-apoptosis,blood coagulation,cytosol,epidermal growth factor receptor signaling pathway,fibroblast growth factor receptor signaling pathway,glucose metabolic process,hypomethylation of CpG island,insulin receptor signaling pathway,insulin receptor substrate binding,kinase activity,lamellipodium,leukocyte migration,nerve growth factor receptor signaling pathway,nucleotide binding,phosphatidylinositol 3-kinase complex,phosphatidylinositol phosphorylation,phosphatidylinositol-4,5-bisphosphate 3-kinase activity,phosphatidylinositol-mediated signaling,phosphotransferase activity, alcohol group as acceptor,platelet activation,positive regulation of peptidyl-serine phosphorylation,protein binding,protein kinase B signaling cascade,protein kinase activator activity,protein phosphorylation,protein serine/threonine kinase activity,regulation of multicellular organism growth,signal transduction	(1S,6BR,9AS,11R,11BR)-9A,11B-DIMETHYL-1-(METHYLOXY)METHYL-3,6,9-TRIOXO-1,6,6B,7,8,9,9A,10,11,11B-DECAHYDRO-3H-FURO4,3,2-DEINDENO4,5-H2BENZOPYRAN-11-YL ACETATE	other	0.00001	481.397	A=1782, C=0, G=218, T=0		A=972/810, C=0/0, G=126/92, T=0/0	1,1,1	
chr4:1803568	C/G	C	SNV		FGFR3	exonic	1	Hotspot	Gain-of-function			HS	COSM715		8.27	p.Ser249Cys		1995	C=0.9173, G=0.0827		Present				+	7	NM_000142.4	c.746C>G	missense	1.9	0.0	112.0	1.0	Immunoglobulin I-set domain,Immunoglobulin domain,Protein kinase domain,Protein tyrosine kinase	rs121913483							ATP binding,JAK-STAT cascade,MAPKKK cascade,bone maturation,bone morphogenesis,chondrocyte differentiation,chondrocyte proliferation,cytoplasmic membrane-bounded vesicle,endochondral bone growth,endochondral ossification,endoplasmic reticulum,fibroblast growth factor binding,fibroblast growth factor receptor signaling pathway,fibroblast growth factor-activated receptor activity,focal adhesion,insulin receptor signaling pathway,integral to plasma membrane,negative regulation of developmental growth,nucleotide binding,peptidyl-tyrosine phosphorylation,plasma membrane,positive regulation of ERK1 and ERK2 cascade,positive regulation of MAPKKK cascade,positive regulation of cell proliferation,positive regulation of phosphatidylinositol 3-kinase activity,positive regulation of phospholipase activity,positive regulation of tyrosine phosphorylation of Stat1 protein,positive regulation of tyrosine phosphorylation of Stat3 protein,protein autophosphorylation,protein binding,protein tyrosine kinase activity,receptor activity,regulation of apoptotic process,skeletal system development	Palifermin,Pazopanib	other,pathogenic	0.00001	233.31	C=1830, G=165		C=953/877, G=86/79	4	
chr4:1808623 - chr4:1739412			FUSION		FGFR3(17) - TACC3(10)			Fusion	Gain-of-function				FGFR3-TACC3.F17T10				113				Present			3.2791e-10		17																				0.0					
chr4:1808661 - chr7:97991744			FUSION		FGFR3(17) - BAIAP2L1(2)			Fusion	Gain-of-function				FGFR3-BAIAP2L1.F17B2.COSF1347				5096				Present		COSF1347	1.4788e-08		17																				0.0					
chr4:1808661 - chr4:1741428			FUSION		FGFR3(17) - TACC3(11)			Fusion	Gain-of-function				FGFR3-TACC3.F17T11				21061				Present			6.1115e-08		17																				0.0					
chr4:25665952 - chr6:117645578			FUSION		SLC34A2(4) - ROS1(34)			Fusion	Gain-of-function				SLC34A2-ROS1.S4R34.COSF1198				2255				Present		COSF1198	6.5436e-09		4																				0.0					
chr4:55152093	ACATCATGCATGAT/TCATCATGCATGAT	ACATCATGCATGAT	SNV		PDGFRA	exonic	1	Hotspot	Gain-of-function			HS	COSM736;COSM12414;COSM12412		TCATCATGCATGAT=11.48, TTGAT=0.00, GA=0.00	p.Asp842Val		1942	ACATCATGCATGAT=0.8852, TCATCATGCATGAT=0.1148, TTGAT=0.0, GA=0.0		Present				+	18	NM_006206.4	c.2525A>T	missense	2.24,0.07,2.24,2.24,1.48,2.24,2.24,2.77,2.77,2.24,-1.08,2.77,2.24,-0.11	0.0	152.0	1.0	Immunoglobulin I-set domain,Immunoglobulin domain,Protein kinase domain,Protein tyrosine kinase	rs121908585,rs121908588,rs121913257,rs121913258,rs121913259,rs121913260,rs121913261,rs121913262,rs121913263,rs121913264,rs121913266,rs121913267,rs121913268,rs121913269							ATP binding,Leydig cell differentiation,adrenal gland development,cardiac myofibril assembly,cell activation,cell chemotaxis,cellular response to amino acid stimulus,cytoplasm,elevation of cytosolic calcium ion concentration,embryonic cranial skeleton morphogenesis,embryonic digestive tract morphogenesis,embryonic skeletal system morphogenesis,estrogen metabolic process,extracellular matrix organization,face morphogenesis,female gonad development,gliogenesis,growth factor binding,in utero embryonic development,inner ear development,integral to plasma membrane,intrinsic to plasma membrane,lung development,luteinization,male genitalia development,metanephric glomerular capillary formation,multicellular organismal development,negative regulation of platelet activation,nucleotide binding,nucleus,odontogenesis of dentin-containing tooth,palate development,peptidyl-tyrosine phosphorylation,phosphatidylinositol 3-kinase binding,phosphatidylinositol-mediated signaling,plasma membrane,platelet aggregation,platelet-derived growth factor alpha-receptor activity,platelet-derived growth factor binding,platelet-derived growth factor receptor binding,platelet-derived growth factor receptor signaling pathway,platelet-derived growth factor receptor-alpha signaling pathway,positive regulation of DNA replication,positive regulation of ERK1 and ERK2 cascade,positive regulation of cell migration,positive regulation of cell proliferation,positive regulation of fibroblast proliferation,positive regulation of phosphatidylinositol 3-kinase activity,positive regulation of phosphatidylinositol 3-kinase cascade,positive regulation of phospholipase C activity,protein autophosphorylation,protein homodimerization activity,protein tyrosine kinase activity,receptor activity,regulation of actin cytoskeleton reorganization,regulation of chemotaxis,regulation of mesenchymal stem cell differentiation,response to cytokine stimulus,response to estradiol stimulus,response to hormone stimulus,response to hyperoxia,response to inorganic substance,retina vasculature development in camera-type eye,signal transduction involved in regulation of gene expression,transmembrane receptor protein tyrosine kinase activity,vascular endothelial growth factor receptor signaling pathway,vascular endothelial growth factor-activated receptor activity,wound healing	Becaplermin,Imatinib,Pazopanib,Sunitinib	other	0.00001	526.837	ACATCATGCATGAT=1719, TCATCATGCATGAT=223, TTGAT=0, GA=0		ACATCATGCATGAT=802/917, TCATCATGCATGAT=103/120, TTGAT=0/0, GA=0/0	1,1,1	
chr4:55599321	A/T	A	SNV		KIT	exonic	1	Hotspot	Gain-of-function			HS	COSM24675;COSM12711;COSM1314		C=0.00, G=0.00, T=10.29	p.Asp816Val		1993	A=0.8971, C=0.0, G=0.0, T=0.1029		Present				+	17	NM_000222.2	c.2447A>T	missense	2.15	0.0	152.0	0.991	Immunoglobulin I-set domain,Immunoglobulin domain,Protein kinase domain,Protein tyrosine kinase	rs121913507							ATP binding,activation of MAPK activity,cytokine binding,cytokine-mediated signaling pathway,cytoplasm,external side of plasma membrane,extracellular space,germ cell programmed cell death,glycosphingolipid metabolic process,hemopoiesis,integral to membrane,intracellular protein kinase cascade,lymphoid progenitor cell differentiation,male gonad development,mast cell differentiation,mast cell proliferation,melanocyte differentiation,metal ion binding,myeloid progenitor cell differentiation,negative regulation of programmed cell death,nucleotide binding,nucleus,peptidyl-tyrosine phosphorylation,plasma membrane,positive regulation of JAK-STAT cascade,positive regulation of MAPKKK cascade,positive regulation of gene expression,positive regulation of phosphatidylinositol 3-kinase activity,positive regulation of phosphatidylinositol 3-kinase cascade,positive regulation of phospholipase C activity,positive regulation of sequence-specific DNA binding transcription factor activity,positive regulation of tyrosine phosphorylation of Stat1 protein,positive regulation of tyrosine phosphorylation of Stat3 protein,positive regulation of tyrosine phosphorylation of Stat5 protein,protein autophosphorylation,protein binding,protein homodimerization activity,protein tyrosine kinase activity,receptor activity,receptor signaling protein tyrosine kinase activity,regulation of cell proliferation,regulation of developmental pigmentation,response to radiation,signal transduction,spermatid development,spermatogenesis,stem cell factor receptor activity,stem cell maintenance,transmembrane receptor protein tyrosine kinase activity,transmembrane receptor protein tyrosine kinase signaling pathway	Adenosine-5'-Diphosphate,Dasatinib,Imatinib,Nilotinib,Pazopanib,Phosphonotyrosine,Sorafenib,Sunitinib	pathogenic	0.00001	418.263	A=1788, C=0, G=0, T=205		A=787/1001, C=0/0, G=0/0, T=90/115	1,1,1	
chr5:149784242 - chr6:117645578			FUSION		CD74(6) - ROS1(34)			Fusion	Gain-of-function				CD74-ROS1.C6R34.COSF1200				4086				Present		COSF1200	1.1857e-08		6																				0.0					
chr7:55242465	GGAATTAAGAGAAGCAACATCT/GACATCT	GGAATTAAGAGAAGCAACATCT	INDEL		EGFR	exonic	15	Hotspot	Gain-of-function			HS	COSM6218;COSM13550;COSM6225;COSM13552;COSM13549;COSM13551;COSM12728;COSM12385;COSM133189		GGAAGCAACATCT=0.00, AATTCCAACATCT=0.00, GACATCT=9.10, AATTCCATCT=0.00, AGCATCT=0.00, AATATCT=0.00, GTCT=0.00, AATT=0.00, G=0.00	p.Glu746_Ala750del		1935	GGAATTAAGAGAAGCAACATCT=0.909, GGAAGCAACATCT=0.0, AATTCCAACATCT=0.0, GACATCT=0.091, AATTCCATCT=0.0, AGCATCT=0.0, AATATCT=0.0, GTCT=0.0, AATT=0.0, G=0.0		Present				+	19	NM_005228.3	c.2236_2250delGAATTAAGAGAAGCA	nonframeshiftDeletion	1.4,2.68,0.98,-0.2,0.39,2.07,-1.46,-0.61,2.56,0.07,2.56,2.07,0.39,2.56,2.56,-0.63,2.07,2.56,-2.87,2.07,1.3,0.86				Furin-like cysteine rich region,Protein kinase domain,Protein tyrosine kinase,Receptor L domain	rs121913229,rs121913421,rs121913422,rs121913423,rs121913424,rs121913425,rs121913426,rs121913427,rs121913435,rs121913436,rs121913437,rs121913438,rs121913439,rs121913440,rs121913441,rs121913442,rs121913463,rs121913464							AP-2 adaptor complex,ATP binding,Golgi apparatus,Golgi membrane,MAP/ERK kinase kinase activity,Shc-EGFR complex,actin filament binding,activation of phospholipase A2 activity by calcium-mediated signaling,activation of phospholipase C activity,axon guidance,basolateral plasma membrane,cell morphogenesis,cell proliferation,cell surface receptor linked signaling pathway,cell-cell adhesion,cerebral cortex cell migration,cytoplasm,digestive tract morphogenesis,double-stranded DNA binding,embryonic placenta development,endocytic vesicle,endoplasmic reticulum,endoplasmic reticulum membrane,endosome,endosome membrane,enzyme binding,epidermal growth factor receptor signaling pathway,epidermal growth factor-activated receptor activity,extracellular region,extracellular space,hair follicle development,identical protein binding,integral to membrane,intracellular,membrane,membrane raft,morphogenesis of an epithelial fold,multicellular organismal development,negative regulation of apoptotic process,negative regulation of epidermal growth factor receptor signaling pathway,negative regulation of protein catabolic process,nitric-oxide synthase regulator activity,nuclear membrane,nucleotide binding,nucleus,ossification,perinuclear region of cytoplasm,plasma membrane,positive regulation of DNA repair,positive regulation of DNA replication,positive regulation of MAP kinase activity,positive regulation of catenin import into nucleus,positive regulation of cell migration,positive regulation of cell proliferation,positive regulation of cyclin-dependent protein kinase activity involved in G1/S,positive regulation of epithelial cell proliferation,positive regulation of fibroblast proliferation,positive regulation of nitric oxide biosynthetic process,positive regulation of phosphorylation,positive regulation of protein kinase B signaling cascade,protein autophosphorylation,protein binding,protein heterodimerization activity,protein insertion into membrane,protein phosphatase binding,protein tyrosine kinase activity,receptor activity,receptor signaling protein tyrosine kinase activity,regulation of nitric-oxide synthase activity,regulation of peptidyl-tyrosine phosphorylation,response to UV-A,response to stress,salivary gland morphogenesis,signal transducer activity,signal transduction,transmembrane receptor protein tyrosine kinase activity,transmembrane signaling receptor activity	Cetuximab,Erlotinib,Flavopiridol,Gefitinib,Lapatinib,Lidocaine,N-4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL-ACRYLAMIDE,Panitumumab,S-{3-(4-ANILINOQUINAZOLIN-6-YL)AMINO-3-OXOPROPYL}-L-CYSTEINE,Trastuzumab,ZD-6474		0.00001	293.318	GGAATTAAGAGAAGCAACATCT=1759, GGAAGCAACATCT=0, AATTCCAACATCT=0, GACATCT=176, AATTCCATCT=0, AGCATCT=0, AATATCT=0, GTCT=0, AATT=0, G=0		GGAATTAAGAGAAGCAACATCT=1097/662, GGAAGCAACATCT=0/0, AATTCCAACATCT=0/0, GACATCT=106/70, AATTCCATCT=0/0, AGCATCT=0/0, AATATCT=0/0, GTCT=0/0, AATT=0/0, G=0/0	2,2,2,2,2,2,2,2,2	
chr7:55249012	C/CGGT	C	INDEL		EGFR,EGFR-AS1	exonic, exonic_nc	3	Hotspot	Gain-of-function			HS	COSM1651743;COSM20886;COSM1238029;COSM48921;COSM655155;COSM12378		CAGCGTCGAA=0.00, CGCACCGTGG=0.00, CGGCACA=0.00, CGGGTTA=0.00, CGGGTTT=0.00, CGGT=10.48	p.Asp770_Asn771insGly		1985	C=0.8952, CAGCGTCGAA=0.0, CGCACCGTGG=0.0, CGGCACA=0.0, CGGGTTA=0.0, CGGGTTT=0.0, CGGT=0.1048		Present				+, -	20	NM_005228.3, NR_047551.1	c.2310_2311insGGT	nonframeshiftInsertion	2.76				Furin-like cysteine rich region,Protein kinase domain,Protein tyrosine kinase,Receptor L domain								AP-2 adaptor complex,ATP binding,Golgi apparatus,Golgi membrane,MAP/ERK kinase kinase activity,Shc-EGFR complex,actin filament binding,activation of phospholipase A2 activity by calcium-mediated signaling,activation of phospholipase C activity,axon guidance,basolateral plasma membrane,cell morphogenesis,cell proliferation,cell surface receptor linked signaling pathway,cell-cell adhesion,cerebral cortex cell migration,cytoplasm,digestive tract morphogenesis,double-stranded DNA binding,embryonic placenta development,endocytic vesicle,endoplasmic reticulum,endoplasmic reticulum membrane,endosome,endosome membrane,enzyme binding,epidermal growth factor receptor signaling pathway,epidermal growth factor-activated receptor activity,extracellular region,extracellular space,hair follicle development,identical protein binding,integral to membrane,intracellular,membrane,membrane raft,morphogenesis of an epithelial fold,multicellular organismal development,negative regulation of apoptotic process,negative regulation of epidermal growth factor receptor signaling pathway,negative regulation of protein catabolic process,nitric-oxide synthase regulator activity,nuclear membrane,nucleotide binding,nucleus,ossification,perinuclear region of cytoplasm,plasma membrane,positive regulation of DNA repair,positive regulation of DNA replication,positive regulation of MAP kinase activity,positive regulation of catenin import into nucleus,positive regulation of cell migration,positive regulation of cell proliferation,positive regulation of cyclin-dependent protein kinase activity involved in G1/S,positive regulation of epithelial cell proliferation,positive regulation of fibroblast proliferation,positive regulation of nitric oxide biosynthetic process,positive regulation of phosphorylation,positive regulation of protein kinase B signaling cascade,protein autophosphorylation,protein binding,protein heterodimerization activity,protein insertion into membrane,protein phosphatase binding,protein tyrosine kinase activity,receptor activity,receptor signaling protein tyrosine kinase activity,regulation of nitric-oxide synthase activity,regulation of peptidyl-tyrosine phosphorylation,response to UV-A,response to stress,salivary gland morphogenesis,signal transducer activity,signal transduction,transmembrane receptor protein tyrosine kinase activity,transmembrane signaling receptor activity	Cetuximab,Erlotinib,Flavopiridol,Gefitinib,Lapatinib,Lidocaine,N-4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL-ACRYLAMIDE,Panitumumab,S-{3-(4-ANILINOQUINAZOLIN-6-YL)AMINO-3-OXOPROPYL}-L-CYSTEINE,Trastuzumab,ZD-6474		0.00001	432.428	C=1777, CAGCGTCGAA=0, CGCACCGTGG=0, CGGCACA=0, CGGGTTA=0, CGGGTTT=0, CGGT=208		C=1003/774, CAGCGTCGAA=0/0, CGCACCGTGG=0/0, CGGCACA=0/0, CGGGTTA=0/0, CGGGTTT=0/0, CGGT=118/90	2,0,0,0,0,0	
chr7:55249071	C/T	C	SNV		EGFR,EGFR-AS1	exonic, exonic_nc	1	Hotspot	Gain-of-function			HS	COSM6240		10.81	p.Thr790Met		1999	C=0.8919, T=0.1081		Present				+, -	20	NM_005228.3, NR_047551.1	c.2369C>T	missense	2.8	0.0	81.0	1.0	Furin-like cysteine rich region,Protein kinase domain,Protein tyrosine kinase,Receptor L domain	rs121434569							AP-2 adaptor complex,ATP binding,Golgi apparatus,Golgi membrane,MAP/ERK kinase kinase activity,Shc-EGFR complex,actin filament binding,activation of phospholipase A2 activity by calcium-mediated signaling,activation of phospholipase C activity,axon guidance,basolateral plasma membrane,cell morphogenesis,cell proliferation,cell surface receptor linked signaling pathway,cell-cell adhesion,cerebral cortex cell migration,cytoplasm,digestive tract morphogenesis,double-stranded DNA binding,embryonic placenta development,endocytic vesicle,endoplasmic reticulum,endoplasmic reticulum membrane,endosome,endosome membrane,enzyme binding,epidermal growth factor receptor signaling pathway,epidermal growth factor-activated receptor activity,extracellular region,extracellular space,hair follicle development,identical protein binding,integral to membrane,intracellular,membrane,membrane raft,morphogenesis of an epithelial fold,multicellular organismal development,negative regulation of apoptotic process,negative regulation of epidermal growth factor receptor signaling pathway,negative regulation of protein catabolic process,nitric-oxide synthase regulator activity,nuclear membrane,nucleotide binding,nucleus,ossification,perinuclear region of cytoplasm,plasma membrane,positive regulation of DNA repair,positive regulation of DNA replication,positive regulation of MAP kinase activity,positive regulation of catenin import into nucleus,positive regulation of cell migration,positive regulation of cell proliferation,positive regulation of cyclin-dependent protein kinase activity involved in G1/S,positive regulation of epithelial cell proliferation,positive regulation of fibroblast proliferation,positive regulation of nitric oxide biosynthetic process,positive regulation of phosphorylation,positive regulation of protein kinase B signaling cascade,protein autophosphorylation,protein binding,protein heterodimerization activity,protein insertion into membrane,protein phosphatase binding,protein tyrosine kinase activity,receptor activity,receptor signaling protein tyrosine kinase activity,regulation of nitric-oxide synthase activity,regulation of peptidyl-tyrosine phosphorylation,response to UV-A,response to stress,salivary gland morphogenesis,signal transducer activity,signal transduction,transmembrane receptor protein tyrosine kinase activity,transmembrane signaling receptor activity	Cetuximab,Erlotinib,Flavopiridol,Gefitinib,Lapatinib,Lidocaine,N-4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL-ACRYLAMIDE,Panitumumab,S-{3-(4-ANILINOQUINAZOLIN-6-YL)AMINO-3-OXOPROPYL}-L-CYSTEINE,Trastuzumab,ZD-6474	pathogenic	0.00001	471.468	C=1783, T=216		C=1004/779, T=123/93	1	
chr7:55259515	TG/GG	TG	SNV		EGFR	exonic	1	Hotspot	Gain-of-function			HS	COSM29578;COSM6224;COSM133630;COSM12429		AG=0.00, GG=11.16, GA=0.00, GT=0.00	p.Leu858Arg		1998	TG=0.8884, AG=0.0, GG=0.1116, GA=0.0, GT=0.0		Present				+	21	NM_005228.3	c.2573T>G	missense	2.18,2.69	0.0	102.0	1.0	Furin-like cysteine rich region,Protein kinase domain,Protein tyrosine kinase,Receptor L domain	rs121434568							AP-2 adaptor complex,ATP binding,Golgi apparatus,Golgi membrane,MAP/ERK kinase kinase activity,Shc-EGFR complex,actin filament binding,activation of phospholipase A2 activity by calcium-mediated signaling,activation of phospholipase C activity,axon guidance,basolateral plasma membrane,cell morphogenesis,cell proliferation,cell surface receptor linked signaling pathway,cell-cell adhesion,cerebral cortex cell migration,cytoplasm,digestive tract morphogenesis,double-stranded DNA binding,embryonic placenta development,endocytic vesicle,endoplasmic reticulum,endoplasmic reticulum membrane,endosome,endosome membrane,enzyme binding,epidermal growth factor receptor signaling pathway,epidermal growth factor-activated receptor activity,extracellular region,extracellular space,hair follicle development,identical protein binding,integral to membrane,intracellular,membrane,membrane raft,morphogenesis of an epithelial fold,multicellular organismal development,negative regulation of apoptotic process,negative regulation of epidermal growth factor receptor signaling pathway,negative regulation of protein catabolic process,nitric-oxide synthase regulator activity,nuclear membrane,nucleotide binding,nucleus,ossification,perinuclear region of cytoplasm,plasma membrane,positive regulation of DNA repair,positive regulation of DNA replication,positive regulation of MAP kinase activity,positive regulation of catenin import into nucleus,positive regulation of cell migration,positive regulation of cell proliferation,positive regulation of cyclin-dependent protein kinase activity involved in G1/S,positive regulation of epithelial cell proliferation,positive regulation of fibroblast proliferation,positive regulation of nitric oxide biosynthetic process,positive regulation of phosphorylation,positive regulation of protein kinase B signaling cascade,protein autophosphorylation,protein binding,protein heterodimerization activity,protein insertion into membrane,protein phosphatase binding,protein tyrosine kinase activity,receptor activity,receptor signaling protein tyrosine kinase activity,regulation of nitric-oxide synthase activity,regulation of peptidyl-tyrosine phosphorylation,response to UV-A,response to stress,salivary gland morphogenesis,signal transducer activity,signal transduction,transmembrane receptor protein tyrosine kinase activity,transmembrane signaling receptor activity	Cetuximab,Erlotinib,Flavopiridol,Gefitinib,Lapatinib,Lidocaine,N-4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL-ACRYLAMIDE,Panitumumab,S-{3-(4-ANILINOQUINAZOLIN-6-YL)AMINO-3-OXOPROPYL}-L-CYSTEINE,Trastuzumab,ZD-6474	other	0.00001	503.273	TG=1775, AG=0, GG=223, GA=0, GT=0		TG=812/963, AG=0/0, GG=85/138, GA=0/0, GT=0/0	1,1,1,1	
chr7:116411708 - chr7:116414934			FUSION		MET(13) - MET(15)			Fusion	Gain-of-function				MET-MET.M13M15				1519				Present			4.4079e-09		13																				0.0					
chr7:140453136	ACTG/TCTG	ACTG	SNV		BRAF	exonic	1	Hotspot	Gain-of-function			HS	COSM26504;COSM6137;COSM18443;COSM476;COSM1583011;COSM474;COSM249889;COSM473;COSM1127;COSM1735763		ACTGTAGCTAGACCAAAATCTG=0.00, CCTG=0.00, GCTG=0.00, TCTG=11.16, CGTG=0.00, CTTG=0.00, TGTG=0.00, TTTG=0.00, CTCG=0.00, TTTA=0.00	p.Val600Glu		1981	ACTG=0.8884, ACTGTAGCTAGACCAAAATCTG=0.0, CCTG=0.0, GCTG=0.0, TCTG=0.1116, CGTG=0.0, CTTG=0.0, TGTG=0.0, TTTG=0.0, CTCG=0.0, TTTA=0.0		Present				-	15	NM_004333.4	c.1799T>A	missense	2.17,2.69,2.17,2.69	0.0	121.0	0.971	C1-like domain,Phorbol esters/diacylglycerol binding domain (C1 domain),Protein kinase domain,Protein tyrosine kinase,Raf-like Ras-binding domain	rs113488022,rs121913227,rs121913374,rs121913375,rs121913377,rs121913378							ATP binding,MAP kinase kinase kinase activity,activation of MAPKK activity,anti-apoptosis,cytoplasm,cytosol,metal ion binding,mitogen-activated protein kinase kinase binding,negative regulation of apoptotic process,negative regulation of neuron apoptosis,nerve growth factor receptor signaling pathway,nucleotide binding,nucleus,organ morphogenesis,plasma membrane,positive regulation of ERK1 and ERK2 cascade,positive regulation of peptidyl-serine phosphorylation,protein binding,protein heterodimerization activity,protein kinase activity,protein phosphorylation,protein serine/threonine kinase activity,receptor signaling protein activity,response to cAMP,response to peptide hormone stimulus,small GTPase mediated signal transduction,soluble fraction,synaptic transmission,synaptosome	(1E)-5-(1-piperidin-4-yl-3-pyridin-4-yl-1H-pyrazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime,N-{2,4-difluoro-3-(5-pyridin-3-yl-1H-pyrrolo2,3-bpyridin-3-yl)carbonylphenyl}ethanesulfonamide,N-{3-(5-chloro-1H-pyrrolo2,3-bpyridin-3-yl)carbonyl-2,4-difluorophenyl}propane-1-sulfonamide,Sorafenib	other,pathogenic	0.00001	506.394	ACTG=1760, ACTGTAGCTAGACCAAAATCTG=0, CCTG=0, GCTG=0, TCTG=221, CGTG=0, CTTG=0, TGTG=0, TTTG=0, CTCG=0, TTTA=0		ACTG=866/894, ACTGTAGCTAGACCAAAATCTG=0/0, CCTG=0/0, GCTG=0/0, TCTG=101/120, CGTG=0/0, CTTG=0/0, TGTG=0/0, TTTG=0/0, CTCG=0/0, TTTA=0/0	1,1,1,1,1,1,1,1,1,1	
chr9:5073770	GTCT/TTCT	GTCT	SNV		JAK2	exonic	1	Hotspot	Gain-of-function			HS	COSM29117;COSM12600;COSM29821;COSM27624		ATCT=0.00, TTCT=10.36, TTCC=0.00, TTTC=0.00	p.Val617Phe		1989	GTCT=0.8964, ATCT=0.0, TTCT=0.1036, TTCC=0.0, TTTC=0.0		Present				+	14	NM_004972.3	c.1849G>T	missense	2.58,2.09,0.25,2.09	0.0	50.0	0.996	Protein kinase domain,Protein tyrosine kinase	rs77375493		0.0	2.0E-4	2.0E-4	2.0E-4		ATP binding,JAK-STAT cascade,JAK-STAT cascade involved in growth hormone signaling pathway,SH2 domain binding,STAT protein import into nucleus,actin filament polymerization,activation of JAK2 kinase activity,activation of caspase activity by protein phosphorylation,apoptotic process,blood coagulation,caveola,cell differentiation,cellular component movement,chromatin modification,cytokine-mediated signaling pathway,cytoplasm,cytoskeleton,cytosol,endomembrane system,enzyme linked receptor protein signaling pathway,erythrocyte differentiation,growth hormone receptor binding,growth hormone receptor signaling pathway,heme binding,histone H3-Y41 phosphorylation,histone binding,histone kinase activity (H3-Y41 specific),innate immune response,interferon-gamma-mediated signaling pathway,interleukin-12 receptor binding,interleukin-12-mediated signaling pathway,intracellular protein kinase cascade,intracellular signal transduction,mammary gland epithelium development,membrane,membrane raft,mesoderm development,negative regulation of DNA binding,negative regulation of cell proliferation,non-membrane spanning protein tyrosine kinase activity,nucleotide binding,nucleus,peptidyl-tyrosine phosphorylation,positive regulation of apoptotic process,positive regulation of cell-substrate adhesion,positive regulation of growth hormone receptor signaling pathway,positive regulation of nitric-oxide synthase biosynthetic process,positive regulation of peptidyl-tyrosine phosphorylation,positive regulation of phosphatidylinositol 3-kinase cascade,positive regulation of tumor necrosis factor production,positive regulation of tyrosine phosphorylation of Stat3 protein,positive regulation of tyrosine phosphorylation of Stat5 protein,protein autophosphorylation,protein binding,protein kinase activity,protein kinase binding,protein phosphorylation,protein tyrosine kinase activity,receptor binding,regulation of inflammatory response,regulation of interferon-gamma-mediated signaling pathway,response to antibiotic,response to interleukin-12,response to lipopolysaccharide,response to tumor necrosis factor,signal transduction,tumor necrosis factor-mediated signaling pathway,tyrosine phosphorylation of STAT protein	2-(1,1-DIMETHYLETHYL)9-FLUORO-3,6-DIHYDRO-7H-BENZH-IMIDAZ4,5-FISOQUINOLIN-7-ONE,3-{(3R,4R)-4-methyl-3-methyl(7H-pyrrolo2,3-dpyrimidin-4-yl)aminopiperidin-1-yl}-3-oxopropanenitrile,4-(2-{4-(CYCLOPROPYLCARBAMOYL)AMINO-1H-PYRAZOL-3-YL}-1H-BENZIMIDAZOL-6-YL)METHYLMORPHOLIN-4-IUM,4-(3-amino-1H-indazol-5-yl)-N-tert-butylbenzenesulfonamide,5-phenyl-1H-indazol-3-amine	other	0.00001	419.009	GTCT=1783, ATCT=0, TTCT=206, TTCC=0, TTTC=0		GTCT=1021/762, ATCT=0/0, TTCT=120/86, TTCC=0/0, TTTC=0/0	1,1,1,1	
chr9:80409488	TG/GG	TG	SNV		GNAQ	exonic	1	Hotspot	Gain-of-function			HS	COSM28757;COSM28760;COSM28758;COSM28759		AG=0.00, CG=0.00, GG=10.52, AA=0.00	p.Gln209Pro		1997	TG=0.8948, AG=0.0, CG=0.0, GG=0.1052, AA=0.0		Present				-	5	NM_002072.4	c.626A>C	missense	2.17,2.68	0.0	76.0	0.999	G-protein alpha subunit	rs121913492							G-protein beta/gamma-subunit complex binding,G-protein coupled receptor binding,G-protein coupled receptor signaling pathway,GTP binding,GTP catabolic process,GTPase activator activity,GTPase activity,activation of adenylate cyclase activity by G-protein signaling pathway,activation of phospholipase C activity,activation of phospholipase C activity by dopamine receptor signaling pathway,behavior,blood coagulation,cytoplasm,developmental pigmentation,embryonic digit morphogenesis,extrinsic to internal side of plasma membrane,forebrain neuron development,glutamate signaling pathway,guanyl nucleotide binding,guanyl-nucleotide exchange factor activity,heart development,heterotrimeric G-protein complex,membrane fraction,metal ion binding,negative regulation of protein kinase activity,neuron remodeling,nucleotide binding,phospholipase C activity,plasma membrane,platelet activation,positive regulation of GTPase activity,post-embryonic development,protein ADP-ribosylation,protein binding,protein stabilization,regulation of action potential,regulation of catenin import into nucleus,regulation of melanocyte differentiation,signal transducer activity,skeletal system development		untested	0.00001	440.385	TG=1787, AG=0, CG=0, GG=210, AA=0		TG=871/916, AG=0/0, CG=0/0, GG=103/107, AA=0/0	3,3,3,3	
chr10:32306070 - chr10:43609927			FUSION		KIF5B(24) - RET(11)			Fusion	Gain-of-function				KIF5B-RET.K24R11.COSF1262				16195				Present		COSF1262	4.6995e-08		24																				0.0					
chr10:43617416	T/C	T	SNV		RET	exonic	1	Hotspot	Gain-of-function			HS	COSM965		11.06	p.Met918Thr		1999	T=0.8894, C=0.1106		Present				+	16	NM_020975.4	c.2753T>C	missense	2.2	0.0	81.0	0.999	Cadherin domain,Protein kinase domain,Protein tyrosine kinase	rs74799832							ATP binding,MAPKKK cascade,calcium ion binding,cellular response to retinoic acid,embryonic epithelial tube formation,endosome membrane,enteric nervous system development,homophilic cell adhesion,induction of apoptosis,integral to membrane,integral to plasma membrane,membrane,membrane protein proteolysis,nervous system development,neural crest cell migration,neuron maturation,nucleotide binding,positive regulation of cell adhesion mediated by integrin,positive regulation of cell migration,positive regulation of metanephric glomerulus development,positive regulation of neuron projection development,positive regulation of transcription, DNA-dependent,posterior midgut development,protein binding,protein phosphorylation,protein tyrosine kinase activity,receptor activity,regulation of cell adhesion,response to pain,signal transduction,transmembrane receptor protein tyrosine kinase activity,ureteric bud development	1-Ter-Butyl-3-P-Tolyl-1h-Pyrazolo3,4-DPyrimidin-4-Ylamine,4-BROMO-2-FLUORO-N-(4E)-6-METHOXY-7-(1-METHYLPIPERIDIN-4-YL)METHOXYQUINAZOLIN-4(1H)-YLIDENEANILINE,Imatinib	other,pathogenic	0.00001	498.34	T=1778, C=221		T=913/865, C=117/104	1	
chr10:51582939 - chr10:43612031			FUSION		NCOA4(7) - RET(12)			Fusion	Gain-of-function				NCOA4-RET.N7R12				23546				Present			6.8327e-08		7																				0.0					
chr12:12022903 - chr15:88483984			FUSION		ETV6(5) - NTRK3(15)			Fusion	Gain-of-function				ETV6-NTRK3.E5N15.COSF571.1				37490				Present		COSF571	1.0879e-07		5																				0.0					
chr12:25398284	CC/TC	CC	SNV		KRAS	exonic	1	Hotspot	Gain-of-function			HS	COSM520;COSM522;COSM521;COSM512;COSM514;COSM34144;COSM25081;COSM13643		AA=0.00, AC=0.00, AG=0.00, AT=0.00, GC=0.00, TA=0.00, TC=9.31, TT=0.00	p.Gly12Asp		1997	CC=0.9069, AA=0.0, AC=0.0, AG=0.0, AT=0.0, GC=0.0, TA=0.0, TC=0.0931, TT=0.0		Present				-	2	NM_033360.3	c.35G>A	missense	2.67,2.67	0.0	94.0	0.517	Miro-like protein,Ras family	rs121913529,rs121913530							GDP binding,GMP binding,GTP binding,GTPase activity,LRR domain binding,MAPKKK cascade,Ral guanyl-nucleotide exchange factor activity,Ras protein signal transduction,activation of MAPKK activity,axon guidance,blood coagulation,cytokine-mediated signaling pathway,epidermal growth factor receptor signaling pathway,insulin receptor signaling pathway,leukocyte migration,membrane raft,mitochondrion,nerve growth factor receptor signaling pathway,nucleotide binding,plasma membrane,positive regulation of MAP kinase activity,positive regulation of NF-kappaB transcription factor activity,positive regulation of nitric-oxide synthase activity,protein binding,response to glucocorticoid stimulus,response to mineralocorticoid stimulus,signal transduction,small GTPase mediated signal transduction,social behavior	(3,7,11-TRIMETHYL-DODECA-2,6,10-TRIENYLOXYCARBAMOYL)-METHYL-PHOSPHONIC ACID,FARNESYL,FARNESYL DIPHOSPHATE	other	0.00001	321.972	CC=1811, AA=0, AC=0, AG=0, AT=0, GC=0, TA=0, TC=186, TT=0		CC=1015/796, AA=0/0, AC=0/0, AG=0/0, AT=0/0, GC=0/0, TA=0/0, TC=100/86, TT=0/0	2,2,2,2,2,2,2,2	
chr14:105246551	C/T	C	SNV		AKT1	exonic	1	Hotspot	Gain-of-function			HS	COSM33765		13.33	p.Glu17Lys		1995	C=0.8667, T=0.1333		Present				-	3	NM_001014431.1	c.49G>A	missense	2.4	0.0	56.0	1.0	PH domain,Protein kinase C terminal domain,Protein kinase domain,Protein tyrosine kinase	rs121434592,rs34409589							ATP binding,G-protein coupled receptor signaling pathway,RNA metabolic process,T cell costimulation,activation of pro-apoptotic gene products,activation-induced cell death of T cells,anti-apoptosis,apoptotic process,blood coagulation,carbohydrate metabolic process,carbohydrate transport,cell differentiation,cell proliferation,cellular response to insulin stimulus,cytoplasm,cytosol,endocrine pancreas development,enzyme binding,fibroblast growth factor receptor signaling pathway,identical protein binding,induction of apoptosis by intracellular signals,insulin receptor signaling pathway,insulin-like growth factor receptor signaling pathway,intracellular signal transduction,kinase activity,mRNA metabolic process,mammary gland epithelial cell differentiation,membrane fraction,microtubule cytoskeleton,multicellular organismal development,negative regulation of apoptotic process,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,negative regulation of fatty acid beta-oxidation,negative regulation of plasma membrane long-chain fatty acid transport,negative regulation of protein kinase activity,negative regulation of release of cytochrome c from mitochondria,nerve growth factor receptor signaling pathway,nervous system development,nitric oxide biosynthetic process,nitric oxide metabolic process,nitric-oxide synthase regulator activity,nucleoplasm,nucleotide binding,nucleus,peptidyl-serine phosphorylation,phosphatidylinositol-3,4,5-trisphosphate binding,phosphatidylinositol-3,4-bisphosphate binding,phosphatidylinositol-mediated signaling,phosphorylation,plasma membrane,platelet activation,positive regulation of anti-apoptosis,positive regulation of blood vessel endothelial cell migration,positive regulation of cell growth,positive regulation of cellular protein metabolic process,positive regulation of cyclin-dependent protein kinase activity involved in G1/S,positive regulation of establishment of protein localization in plasma membrane,positive regulation of fat cell differentiation,positive regulation of glucose import,positive regulation of glucose metabolic process,positive regulation of glycogen biosynthetic process,positive regulation of lipid biosynthetic process,positive regulation of nitric oxide biosynthetic process,positive regulation of nitric-oxide synthase activity,positive regulation of peptidyl-serine phosphorylation,positive regulation of protein phosphorylation,positive regulation of sequence-specific DNA binding transcription factor activity,protein autophosphorylation,protein binding,protein import into nucleus, translocation,protein kinase activity,protein modification process,protein phosphorylation,protein serine/threonine kinase activity,regulation of G1/S transition checkpoint,regulation of cell migration,regulation of glycogen biosynthetic process,regulation of neuron projection development,regulation of nitric-oxide synthase activity,regulation of translation,response to UV-A,response to fluid shear stress,response to heat,signal transduction,transport	5-(5-chloro-7H-pyrrolo2,3-dpyrimidin-4-yl)-4,5,6,7-tetrahydro-1H-imidazo4,5-cpyridine,Adenosine triphosphate,Arsenic trioxide,Inositol 1,3,4,5-Tetrakisphosphate,N-2-(5-methyl-4H-1,2,4-triazol-3-yl)phenyl-7H-pyrrolo2,3-dpyrimidin-4-amine	other,pathogenic	0.00001	762.244	C=1729, T=266		C=918/811, T=125/141	4	
chr17:37880981	A/AGCATACGTGATG	A	INDEL		ERBB2	exonic	12	Hotspot	Gain-of-function			HS	COSM20959		9.09	p.Glu770_Ala771insAlaTyrValMet		1981	A=0.9091, AGCATACGTGATG=0.0909		Present				+	20	NM_004448.3	c.2324_2325insATACGTGATGGC	nonframeshiftInsertion	0.03				Furin-like cysteine rich region,Protein kinase domain,Protein tyrosine kinase,Receptor L domain								ATP binding,ErbB-3 class receptor binding,Hsp90 protein binding,RNA polymerase I core binding,apical plasma membrane,axon guidance,basal plasma membrane,basolateral plasma membrane,cell proliferation,cell surface receptor linked signaling pathway,cytoplasm,endosome membrane,enzyme linked receptor protein signaling pathway,epidermal growth factor receptor signaling pathway,epidermal growth factor-activated receptor activity,estrus,glial cell differentiation,glycoprotein binding,growth factor binding,heart development,identical protein binding,integral to membrane,lateral loop,liver development,mammary gland development,mammary gland involution,membrane raft,microvillus,motor axon guidance,myelination,negative regulation of apoptotic process,negative regulation of immature T cell proliferation in thymus,nervous system development,neuromuscular junction development,nucleotide binding,nucleus,perinuclear region of cytoplasm,peripheral nervous system development,phosphatidylinositol 3-kinase cascade,phosphatidylinositol-mediated signaling,plasma membrane,positive regulation of MAP kinase activity,positive regulation of MAPKKK cascade,positive regulation of Ras protein signal transduction,positive regulation of cell adhesion,positive regulation of cell growth,positive regulation of epithelial cell proliferation,positive regulation of phosphatidylinositol 3-kinase cascade,positive regulation of transcription from RNA polymerase I promoter,positive regulation of transcription from RNA polymerase III promoter,positive regulation of translation,postsynaptic membrane,protein C-terminus binding,protein autophosphorylation,protein binding,protein dimerization activity,protein heterodimerization activity,protein phosphatase binding,protein phosphorylation,protein tyrosine kinase activity,receptor activity,receptor complex,receptor signaling protein tyrosine kinase activity,regulation of ERK1 and ERK2 cascade,regulation of angiogenesis,regulation of microtubule-based process,regulation of transcription, DNA-dependent,response to axon injury,response to drug,response to progesterone stimulus,signal transduction,skeletal muscle tissue development,sympathetic nervous system development,tongue development,transmembrane receptor protein tyrosine kinase activity,transmembrane receptor protein tyrosine kinase signaling pathway,transmembrane signaling receptor activity,ubiquitin protein ligase binding,wound healing	Lapatinib,Trastuzumab		0.00001	302.335	A=1801, AGCATACGTGATG=180		A=1152/649, AGCATACGTGATG=121/59	1	
chr19:3118942	AG/TG	AG	SNV		GNA11	exonic	1	Hotspot	Gain-of-function			HS	COSM52970;COSM1666996;COSM52969;COSM52971;COSM52972		CG=0.00, GG=0.00, TA=0.00, TG=12.15, TT=0.00	p.Gln209Leu		1992	AG=0.8785, CG=0.0, GG=0.0, TA=0.0, TG=0.1215, TT=0.0		Present				+	5	NM_002067.4	c.626A>T	missense	1.26,1.53	0.0	113.0	0.986	G-protein alpha subunit								G-protein beta/gamma-subunit complex binding,G-protein coupled receptor binding,G-protein coupled receptor signaling pathway,G-protein signaling, coupled to cAMP nucleotide second messenger,GTP binding,GTP catabolic process,GTPase activity,activation of phospholipase C activity by dopamine receptor signaling pathway,blood coagulation,cytoplasm,developmental pigmentation,extrinsic to internal side of plasma membrane,guanyl nucleotide binding,guanyl-nucleotide exchange factor activity,heart development,heterotrimeric G-protein complex,membrane fraction,metal ion binding,nucleotide binding,phospholipase C activity,plasma membrane,platelet activation,protein ADP-ribosylation,regulation of action potential,regulation of melanocyte differentiation,signal transducer activity,signal transduction,skeletal system development			0.00001	620.931	AG=1750, CG=0, GG=0, TA=0, TG=242, TT=0		AG=636/1114, CG=0/0, GG=0/0, TA=0/0, TG=81/161, TT=0/0	1,1,1,1,1	
chr21:42880007 - chr21:39956869			FUSION		TMPRSS2(1) - ERG(2)			Fusion	Gain-of-function				TMPRSS2-ERG.T1E2.COSF23.1				1381				Present		COSF23	4.0074e-09		1																				0.0					
